BioPharma Resources

Drug Trial Radar · NCT07196722

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,092 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,092

Planned (sponsor's estimate)

Start

Oct 3, 2025

Primary completion

Sep 19, 2028

Study completion Oct 6, 2032

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Sep 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

Conditions

  • Crohn Disease

Interventions

  • IcotrokinraDrug

    Icotrokinra will be administered orally, daily.

  • PlaceboDrug

    Matching placebo will be administered orally, daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Induction Study 1: Number of Participants with Clinical Response at Week 12Time frame: At Week 12
  2. Induction Study 2: Number of Participants with Clinical Remission at Week 12 (Co-Primary Endpoint)Time frame: At Week 12
  3. Induction Study 2: Number of Participants with Endoscopic Response at Week 12 (Co-Primary Endpoint)Time frame: At Week 12
  4. Maintenance Study: Number of Participants with Clinical Remission at Week 40 (Co-Primary Endpoint)Time frame: At Week 40
  5. Maintenance Study: Number of Participants with Endoscopic Response at Week 40 (Co-Primary Endpoint)Time frame: At Week 40

Locations

395 sites in 28 countries. Site status is shown where the registry gives one.

  • AZ Gastro Care

    Chandler, Arizona · Recruiting

  • Research Solutions of Arizona

    Litchfield Park, Arizona · Recruiting

  • Mayo Clinic

    Scottsdale, Arizona · Recruiting

  • Clinnova Research

    Anaheim, California · Recruiting

  • Alliance Research Institute, LLC - Canoga Park

    Canoga Park, California · Completed

  • Southern California Research Center

    Coronado, California · Recruiting

  • Om Research, LLC 1

    Lancaster, California · Recruiting

  • TLC Clinical Research Inc

    Los Angeles, California · Recruiting

  • GastroIntestinal Bioscience

    Los Angeles, California · Recruiting

  • Hoag Memorial Hospital

    Newport Beach, California · Recruiting

  • Om Research, LLC 2

    Oxnard, California · Recruiting

  • Clinical Applications Laboratories, Inc

    San Diego, California · Completed

  • Medical Associates Research Group, Inc.

    San Diego, California · Recruiting

  • University of California San Francisco

    San Francisco, California · Recruiting

  • Peak Gastroenterology Associates

    Colorado Springs, Colorado · Recruiting

  • Nuvance Health Danbury Hospital

    Danbury, Connecticut · Completed

  • American Institute of Research

    Cutler Bay, Florida · Recruiting

  • Nature Coast Clinical Research

    Inverness, Florida · Recruiting

  • Green Leaf Clinical Trials

    Jacksonville, Florida · Completed

  • Florida Research Center Inc.

    Lakewood Rch, Florida · Recruiting

  • Sanchez Clinical Research, Inc

    Miami, Florida · Recruiting

  • GCP Clinical Research

    Tampa, Florida · Recruiting

  • Emory University

    Atlanta, Georgia · Recruiting

  • Atlanta Gastroenterology Associates

    Atlanta, Georgia · Recruiting

  • Children's Center for Digestive Health Care

    Atlanta, Georgia · Recruiting

  • Gastroenterolgy Associates of Central GA

    Macon, Georgia · Recruiting

  • IU Health University Hospital

    Indianapolis, Indiana · Recruiting

  • Kansas Gastroenterology, LLC

    Wichita, Kansas · Recruiting

  • Tri-State Gastroenterology Assoc

    Crestview Hills, Kentucky · Recruiting

  • University of Louisville - MedCenter One

    Louisville, Kentucky · Recruiting

  • Gastroenterology Clinic of Acadiana

    Lafayette, Louisiana · Recruiting

  • Delta Research Partners, LLC

    West Monroe, Louisiana · Recruiting

  • Chevy Chase Clinical Research

    Chevy Chase, Maryland · Recruiting

  • Woodholme Gastroenterology Associates

    Glen Burnie, Maryland · Recruiting

  • Mayo Clinic 1

    Rochester, Minnesota · Recruiting

  • Westchester Putnam Gastroenterology

    Carmel, New York · Recruiting

  • Inflammatory Bowel Disease Center at NYU Langone

    New York, New York · Recruiting

  • Manhattan Clinical Research LLC

    New York, New York · Completed

  • Weill Cornell Medical College

    New York, New York · Recruiting

  • Lenox Hill Hospital

    New York, New York · Recruiting

Showing 40 of 395 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.